Pet Diabetes Care Devices Market Report 2026

The pet diabetes care devices market size has grown strongly in recent years. It will grow from $2.74 billion in 2025 to $2.98 billion in 2026 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to increasing prevalence of diabetes in pets, rising awareness of pet health, growth of veterinary healthcare infrastructure, introduction of homecare monitoring devices, increasing pet ownership.

The pet diabetes care devices market size is expected to see strong growth in the next few years. It will grow to $4.27 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to advancement in wearable glucose monitoring technology, integration of ai in pet healthcare, rising adoption of telemedicine for pets, expansion of smart pet care devices, growth of subscription-based veterinary services. Major trends in the forecast period include remote pet health monitoring, wearable diabetes tracking devices, personalized insulin delivery solutions, mobile app-integrated diabetes management, preventive health analytics for pets.

The growing trend of pet ownership is expected to fuel the expansion of the pet diabetes care device market in the coming years. Pet ownership involves a range of responsibilities, including providing food, water, shelter, physical exercise, and healthcare for domesticated animals such as dogs, cats, fish, birds, and others. Pet diabetes care devices play a crucial role in ensuring the well-being of diabetic pets by facilitating accurate monitoring, precise treatment, and effective communication between pet owners and veterinary professionals. According to data from the World Animal Foundation in October 2023, dog ownership is more prevalent, with 65.1 million dogs compared to 46.5 million cats. Additionally, 11 million households own saltwater fish tanks, surpassing the 2.2 million horses owned by horse owners. The increasing prevalence of pet ownership is thus a significant factor propelling the pet diabetes care device market.

Leading players in the pet diabetes care device market are focusing on developing innovative technologies to reinforce their market position. These innovations include advanced glucose monitoring systems, connected insulin delivery devices, and digital health platforms that enhance accuracy, usability, and long-term diabetes management in pets. For example, in February 2023, Zoetis Inc., a US-based veterinary pharmaceutical company, launched the AlphaTrak 3 blood glucose monitoring system for cats and dogs in the United States. AlphaTrak 3 features a new mobile app that enables pet owners and veterinary professionals to collect, store, and share data. The system allows seamless data exchange and communication through the smartphone app, facilitating real-time sharing of a pet’s glucose levels and other critical information with veterinary practices, thereby providing veterinarians and pet owners with greater confidence in managing diabetic pets. The AlphaTrak 3 device delivers accurate readings in as little as five seconds, faster than the previous AlphaTrak 2 system, and requires only 0.3 microliters of blood, measuring glucose levels from 20 to 750 milligrams per deciliter. The new mobile app also captures more comprehensive data from pet owners than prior systems, including feeding, drinking, activity, and insulin administration schedules.

In September 2025, Merck Animal Health, a US-based provider of veterinary pharmaceuticals, vaccines, and animal health management solutions, established the Diabetes PetCare Alliance in collaboration with Zoetis and Purina Pro Plan Veterinary Diets to improve diabetes management in pets. Through this partnership, the companies pooled resources to offer education, tools, and diabetes management kits to veterinary clinics and pet owners. The collaboration aimed to expand market reach in pet diabetes care, support early diagnosis and ongoing glucose monitoring, and enhance outcomes for diabetic dogs and cats through coordinated educational initiatives and product support. Zoetis Inc. is a US-based provider of veterinary diagnostics and therapeutic products, including blood glucose monitoring systems for pets, while Purina Pro Plan Veterinary Diets (Nestlé Purina PetCare Company) is a US-based provider of specialized therapeutic nutrition for pets, including diets designed for diabetic animals.

Major companies operating in the pet diabetes care devices market are Allison Medical Inc., Zoetis Inc., Becton Dickinson and Company, Boehringer Ingelheim Vetmedica Inc., Henry Schein Animal Health, Apotex Inc., Merck Co. Inc., Trividia Health Inc., UltiMed Inc., ACON Laboratories Inc., i-SENS Inc., TaiDoc Technology Corporation, Abbott Laboratories, Novo Nordisk AS, Covetrus AG, Eli Lilly and Company, Bayer AG, Terumo Corporation, AccuBioTech Co. Ltd., ALR Technologies Inc.

North America was the largest region in the pet diabetes care devices market in 2025. The regions covered in the pet diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pet diabetes care devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the pet diabetes care devices market by increasing the cost of imported medical devices and components, creating supply chain disruptions for glucose monitoring and insulin delivery devices. Regions like North America and Europe, which rely on imported precision devices, are most affected, particularly for high-end wearable monitors. While tariffs raise costs, they also incentivize local manufacturing and innovation, allowing regional manufacturers to gain market share and develop cost-optimized solutions.

The pet diabetes care devices market research report is one of a series of new reports that provides pet diabetes care devices market statistics, including pet diabetes care devices industry global market size, regional shares, competitors with a pet diabetes care devices market share, detailed pet diabetes care devices market segments, market trends and opportunities, and any further data you may need to thrive in the pet diabetes care devices industry. This pet diabetes care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pet diabetes care devices are medical tools designed to manage diabetes in pets through routine check-ups, blood and urine testing, and observation of the animal's weight, appetite, drinking, and urination. These devices play a crucial role in controlling the blood sugar levels of diabetic pets, preventing dangerously high or low levels to ensure their well-being.

The main animal types addressed by pet diabetes care devices include dogs, cats, and horses. Dogs, as four-legged companions commonly kept as pets or used for various purposes, benefit from these devices for monitoring their health when dealing with diabetes. The key devices in this category include glucose monitoring devices and insulin delivery devices. These devices are utilized by various stakeholders, including pet owners for homecare purposes, veterinary hospitals, and other healthcare providers involved in managing diabetes in pets.

The pet diabetes care device market consists of sales of insulin delivery devices, insulin delivery pen amd insulin syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.